NFX-179 topical gel
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NFX-179 topical gel, covering 2022-08-09 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) [Phase 2]